Weizhong Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Weizhong Tian has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Jianguo Xia
Department of Medical Imaging, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, China
4 shared publications Ji Zhang
3 shared publicationsWeiqi Ji
3 shared publicationsFujin Wang
Medical Imaging Department, Taizhou People’s Hospital Affiliated to Nantong University, Taizhou, Jiangsu 225300, China
2 shared publicationsJinhua Chen
2 shared publicationsLiang He
Department of Medical Imaging, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, China
2 shared publications
Latest Publications
- Open Access
- 1 December 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (12) , 12620-12630
A preliminary study of subcortical gray matter nucleus volumetric and morphological changes in diabetic retinopathy
Background: Diabetic retinopathy (DR), a microvascular complication of diabetes, exhibits early neurodegeneration. Retinal and cerebrovascular homology links DR microcirculatory abnormalities to cognitive impairment risk. This study analyzes subcortical gray matter changes in DR patients, providing neuroimaging evidence for central nervous system complications. Methods: In total, 32 patients with DR and 38 normal controls were recruited and underwent T1-weighted imaging three-dimensional (3D)-magnetization‑prepared rapid acquisition gradient echo scanning. Subcortical gray matter nuclei were automatically segmented using Freesurfer software, and volumetric comparisons of these nuclei were further performed with SPSS 26.0 software. Vertex-based shape analysis was employed to compare morphological differences in gray matter nuclei (including the thalamus, caudate nucleus, putamen, globus pallidus, hippocampus, amygdala, and nucleus accumbens) between the two groups. Group-level statistical results were derived using non-parametric permutation tests (1,000 iterations), followed by family-wise error correction for multiple comparisons via threshold-free cluster enhancement (TFCE). Statistical significance was defined as a TFCE-corrected PResults: The covariance analysis results indicated that compared with the control group, the DR patients showed atrophy in the left thalamic volume (PConclusions: The subcortical gray matter nuclei of patients with DR undergo volumetric and morphological abnormal changes. Abnormal changes in these regions provide imaging evidence of the changes in brain structure and neuropathological progression in DR patients, as well as a visual basis for the clinical realization of targeted interventions and treatments to delay cognitive decline.
- 1 December 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (12) , 12620-12630
Open AccessA preliminary study of subcortical gray matter nucleus volumetric and morphological changes in diabetic retinopathy
Background: Diabetic retinopathy (DR), a microvascular complication of diabetes, exhibits early neurodegeneration. Retinal and cerebrovascular homology links DR microcirculatory abnormalities to cognitive impairment risk. This study analyzes subcortical gray matter changes in DR patients, providing neuroimaging evidence for central nervous system complications. Methods: In total, 32 patients with DR and 38 normal controls were recruited and underwent T1-weighted imaging three-dimensional (3D)-magnetization‑prepared rapid acquisition gradient echo scanning. Subcortical gray matter nuclei were automatically segmented using Freesurfer software, and volumetric comparisons of these nuclei were further performed with SPSS 26.0 software. Vertex-based shape analysis was employed to compare morphological differences in gray matter nuclei (including the thalamus, caudate nucleus, putamen, globus pallidus, hippocampus, amygdala, and nucleus accumbens) between the two groups. Group-level statistical results were derived using non-parametric permutation tests (1,000 iterations), followed by family-wise error correction for multiple comparisons via threshold-free cluster enhancement (TFCE). Statistical significance was defined as a TFCE-corrected PResults: The covariance analysis results indicated that compared with the control group, the DR patients showed atrophy in the left thalamic volume (PConclusions: The subcortical gray matter nuclei of patients with DR undergo volumetric and morphological abnormal changes. Abnormal changes in these regions provide imaging evidence of the changes in brain structure and neuropathological progression in DR patients, as well as a visual basis for the clinical realization of targeted interventions and treatments to delay cognitive decline.
- Open Access
- 28 October 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-9
MRI study on hippocampal subfield volume loss and abnormal functional connectivity in patients with diabetic retinopathy
This study aimed to investigate the characteristics of gray matter volume loss in hippocampal subfields and alterations in whole-brain functional connectivity among patients with diabetic retinopathy (DR), and to examine the correlations between these neural changes and neuropsychological scale scores as well as clinical indicators. Structural and functional magnetic resonance imaging (MRI) data, along with neurocognitive assessments, were acquired from 32 patients with diabetic retinopathy (DR) and 38 age- and sex-matched healthy controls using a Siemens 3.0T MRI scanner. Hippocampal subfield volumes were segmented and extracted using the Anatomy toolbox and Restplus (v1.25) within the MATLAB R2022a environment. Subregions demonstrating significant volumetric alterations were identified through subsequent between-group comparisons and defined as regions of interest (ROIs) for seed-based whole-brain functional connectivity (FC) analysis. The relationships between gray matter volume, functional connectivity values, neuropsychological test scores, and clinical indices were investigated using partial correlation analysis. Compared to healthy controls, patients with diabetic retinopathy (DR) exhibited significantly reduced bilateral entorhinal cortex (EC) volumes and increased volume in bilateral dentate gyrus (DG) (P < 0.05, FDR-corrected). Using these volume-altered subregions as regions of interest (ROIs), seed-based functional connectivity (FC) analysis revealed significantly increased FC strength between the left EC and the left caudate nucleus, alongside significantly decreased FC strength between the right DG and the right middle occipital gyrus (GRF correction: voxel-level p < 0.001, cluster-level p < 0.05, two-tailed). Furthermore, partial correlation analyses demonstrated significant positive correlations between the FC strength of the right hippocampal DG subfield and the right middle occipital gyrus, and scores on both the Montreal Cognitive Assessment (MoCA) (r = 0.560, p = 0.001) and the Mini-Mental State Examination (MMSE) (r = 0.541, p = 0.002). Patients with diabetic retinopathy (DR) demonstrate structural alterations in hippocampal subfields and widespread functional dysconnectivity across the brain. Notably, the strength of functional connectivity between the hippocampus and the visual cortex was significantly and positively correlated with cognitive function. This study provides neuroimaging evidence supporting the mechanisms underlying central nervous system complications in DR, suggesting that hippocampal subfield volumes and specific functional connectivity patterns hold potential as neuroimaging biomarkers for early intervention.
- 28 October 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-9
Open AccessMRI study on hippocampal subfield volume loss and abnormal functional connectivity in patients with diabetic retinopathy
This study aimed to investigate the characteristics of gray matter volume loss in hippocampal subfields and alterations in whole-brain functional connectivity among patients with diabetic retinopathy (DR), and to examine the correlations between these neural changes and neuropsychological scale scores as well as clinical indicators. Structural and functional magnetic resonance imaging (MRI) data, along with neurocognitive assessments, were acquired from 32 patients with diabetic retinopathy (DR) and 38 age- and sex-matched healthy controls using a Siemens 3.0T MRI scanner. Hippocampal subfield volumes were segmented and extracted using the Anatomy toolbox and Restplus (v1.25) within the MATLAB R2022a environment. Subregions demonstrating significant volumetric alterations were identified through subsequent between-group comparisons and defined as regions of interest (ROIs) for seed-based whole-brain functional connectivity (FC) analysis. The relationships between gray matter volume, functional connectivity values, neuropsychological test scores, and clinical indices were investigated using partial correlation analysis. Compared to healthy controls, patients with diabetic retinopathy (DR) exhibited significantly reduced bilateral entorhinal cortex (EC) volumes and increased volume in bilateral dentate gyrus (DG) (P < 0.05, FDR-corrected). Using these volume-altered subregions as regions of interest (ROIs), seed-based functional connectivity (FC) analysis revealed significantly increased FC strength between the left EC and the left caudate nucleus, alongside significantly decreased FC strength between the right DG and the right middle occipital gyrus (GRF correction: voxel-level p < 0.001, cluster-level p < 0.05, two-tailed). Furthermore, partial correlation analyses demonstrated significant positive correlations between the FC strength of the right hippocampal DG subfield and the right middle occipital gyrus, and scores on both the Montreal Cognitive Assessment (MoCA) (r = 0.560, p = 0.001) and the Mini-Mental State Examination (MMSE) (r = 0.541, p = 0.002). Patients with diabetic retinopathy (DR) demonstrate structural alterations in hippocampal subfields and widespread functional dysconnectivity across the brain. Notably, the strength of functional connectivity between the hippocampus and the visual cortex was significantly and positively correlated with cognitive function. This study provides neuroimaging evidence supporting the mechanisms underlying central nervous system complications in DR, suggesting that hippocampal subfield volumes and specific functional connectivity patterns hold potential as neuroimaging biomarkers for early intervention.
- 20 June 2025
- Published by Springer Nature in Brain Imaging and Behavior
- p. 1-10
Preliminary study on changes in volume and functional connectivity of hippocampal subregions in patients with diabetic retinopathy
The aim of this study is to investigate the disparities in volumes of hippocampal subfields and alterations in whole-brain functional connectivity among individuals diagnosed with diabetic retinopathy (DR). This study comprised a total of 32 diabetic patients with retinopathy (DR group, n = 32) and 38 healthy adults (HC group, n = 38), who underwent psychological cognitive testing along with structural and functional magnetic resonance imaging. The FreeSurfer software was utilized for the extraction and computation of hippocampal subfield volumes, as well as the overall volumes of the left and right hippocampus. The volumetric comparisons were conducted by employing independent sample t-tests in SPSS 26.0. The functional connectivity comparisons were subjected to statistical analysis using the Matlab software. Age, education level and grnder were used as control variables, and partial correlation analysis was performed to investigate the relationship between differences in volume and functional connectivity values with psychological cognitive test results and clinical indicators. The volume of the left hippocampal tail and fissure, as well as the right hippocampal C3, C4 and fissure regions in the DR patient group, exhibited significant differences compared to the HC group (P < 0.05, FDR < 0.05). Regions of interest were identified based on the segmented volume differences, and compared to the HC group, enhanced connectivity was observed between the left hippocampal tail and the left caudate nucleus (MNI: x,y, z=-6, 12, 9) and the right caudate nucleus (MNI: x,y, z = 9, 12, 12) in DR patients. Additionally, reduced connectivity was observed between the left hippocampal fissure and the right precentral gyrus (MNI: x, y, z = 57, 0, 45) and the right supplementary motor area (MNI: x, y, z = 9, 3, 60). Partial correlation analysis, with age, education level, and gender as covariates, showed no significant associations between the imaging changes and clinical indicators or cognitive scores. The alterations in hippocampal volume and function observed in patients with DR may potentially underlie their cognitive impairment and sensorimotor deficits, thus suggesting a plausible neuropathological mechanism.
- 20 June 2025
- Published by Springer Nature in Brain Imaging and Behavior
- p. 1-10
Preliminary study on changes in volume and functional connectivity of hippocampal subregions in patients with diabetic retinopathy
The aim of this study is to investigate the disparities in volumes of hippocampal subfields and alterations in whole-brain functional connectivity among individuals diagnosed with diabetic retinopathy (DR). This study comprised a total of 32 diabetic patients with retinopathy (DR group, n = 32) and 38 healthy adults (HC group, n = 38), who underwent psychological cognitive testing along with structural and functional magnetic resonance imaging. The FreeSurfer software was utilized for the extraction and computation of hippocampal subfield volumes, as well as the overall volumes of the left and right hippocampus. The volumetric comparisons were conducted by employing independent sample t-tests in SPSS 26.0. The functional connectivity comparisons were subjected to statistical analysis using the Matlab software. Age, education level and grnder were used as control variables, and partial correlation analysis was performed to investigate the relationship between differences in volume and functional connectivity values with psychological cognitive test results and clinical indicators. The volume of the left hippocampal tail and fissure, as well as the right hippocampal C3, C4 and fissure regions in the DR patient group, exhibited significant differences compared to the HC group (P < 0.05, FDR < 0.05). Regions of interest were identified based on the segmented volume differences, and compared to the HC group, enhanced connectivity was observed between the left hippocampal tail and the left caudate nucleus (MNI: x,y, z=-6, 12, 9) and the right caudate nucleus (MNI: x,y, z = 9, 12, 12) in DR patients. Additionally, reduced connectivity was observed between the left hippocampal fissure and the right precentral gyrus (MNI: x, y, z = 57, 0, 45) and the right supplementary motor area (MNI: x, y, z = 9, 3, 60). Partial correlation analysis, with age, education level, and gender as covariates, showed no significant associations between the imaging changes and clinical indicators or cognitive scores. The alterations in hippocampal volume and function observed in patients with DR may potentially underlie their cognitive impairment and sensorimotor deficits, thus suggesting a plausible neuropathological mechanism.
- 14 March 2025
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
Altered Interhemispheric Functional Connectivity in Patients With Diabetic Retinopathy: A Resting-State Functional MRI Study
Objective: Cognitive impairment is a prevalent complication among patients with diabetes mellitus. It tends to be more prominent in patients with diabetic retinopathy (DR) compared with patients with diabetes without DR (NDR). However, the functional connectivity (FC) between bilateral cerebral hemispheres in both remains poorly understood. This study aimed to investigate altered brain connectivity in patients with DR and NDR. Subjects and Methods: We selected 26 patients with DR, 30 patients with NDR, and 30 healthy controls (HCs) to participate in resting-state functional magnetic resonance imaging (rs-fMRI) and high-resolution T1-weighted structural scans. We employed the DPABI toolbox in MATLAB to preprocess the acquired images and applied voxel-mirrored homotopic connectivity (VMHC) and FC analysis methods to estimate differences among the 3 groups. The patients also underwent neuropsychological assessment scales. We utilized partial correlation analysis to explore the associations between aberrant connections and clinical variables as well as neuropsychological characteristics in patients with DR. Receiver operating characteristic (ROC) analysis was conducted to assess the diagnostic performance of VMHC values in distinct brain regions for differentiating DR patients from NDR patients. Results: The results showed significantly altered VMHC values across the 3 groups, including bilateral lingual gyrus (LING_B), superior temporal gyrus (STG_B), and postcentral gyrus (PoCG_B). Significant differences in FC values were found across the LING_B, right cuneus (CUN_R), STG_R, PoCG_B, right precentral gyrus (PreCG_R), right precuneus (PCUN_R), and middle temporal gyrus (MTG_L) among the 3 groups. Moreover, a negative correlation was noted between the VMHC values of LING_B and disease duration in patients with DR. Positive correlations were detected between FC values in PoCG_B and fasting blood glucose (FBG) levels. Furthermore, ROC analysis of the VMHC values demonstrated that combining all the differential regions achieved the highest area under the curve of 0.826. Conclusions: Significant alterations in VMHC and FC may reflect the underlying neuropathology of cognitive dysfunction in DR and NDR. These altered connectivity patterns could serve as neuroimaging biomarkers, offering insights into the early diagnosis and intervention of cognitive impairments in DR patients. Export
- 14 March 2025
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
Altered Interhemispheric Functional Connectivity in Patients With Diabetic Retinopathy: A Resting-State Functional MRI Study
Objective: Cognitive impairment is a prevalent complication among patients with diabetes mellitus. It tends to be more prominent in patients with diabetic retinopathy (DR) compared with patients with diabetes without DR (NDR). However, the functional connectivity (FC) between bilateral cerebral hemispheres in both remains poorly understood. This study aimed to investigate altered brain connectivity in patients with DR and NDR. Subjects and Methods: We selected 26 patients with DR, 30 patients with NDR, and 30 healthy controls (HCs) to participate in resting-state functional magnetic resonance imaging (rs-fMRI) and high-resolution T1-weighted structural scans. We employed the DPABI toolbox in MATLAB to preprocess the acquired images and applied voxel-mirrored homotopic connectivity (VMHC) and FC analysis methods to estimate differences among the 3 groups. The patients also underwent neuropsychological assessment scales. We utilized partial correlation analysis to explore the associations between aberrant connections and clinical variables as well as neuropsychological characteristics in patients with DR. Receiver operating characteristic (ROC) analysis was conducted to assess the diagnostic performance of VMHC values in distinct brain regions for differentiating DR patients from NDR patients. Results: The results showed significantly altered VMHC values across the 3 groups, including bilateral lingual gyrus (LING_B), superior temporal gyrus (STG_B), and postcentral gyrus (PoCG_B). Significant differences in FC values were found across the LING_B, right cuneus (CUN_R), STG_R, PoCG_B, right precentral gyrus (PreCG_R), right precuneus (PCUN_R), and middle temporal gyrus (MTG_L) among the 3 groups. Moreover, a negative correlation was noted between the VMHC values of LING_B and disease duration in patients with DR. Positive correlations were detected between FC values in PoCG_B and fasting blood glucose (FBG) levels. Furthermore, ROC analysis of the VMHC values demonstrated that combining all the differential regions achieved the highest area under the curve of 0.826. Conclusions: Significant alterations in VMHC and FC may reflect the underlying neuropathology of cognitive dysfunction in DR and NDR. These altered connectivity patterns could serve as neuroimaging biomarkers, offering insights into the early diagnosis and intervention of cognitive impairments in DR patients. Export
- Open Access
- 25 October 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2280
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
Pancreatic carcinoma is an aggressive subtype of cancer with poor prognosis, known for its refractory nature. To address this challenge, we have established a stable nanoplatform that combines chemotherapy with photodynamic therapy (PDT) to achieve better curative efficacy. First, we designed and synthesized a disulfide-bonded paclitaxel (PTX)-based prodrug, which was further mixed with gemcitabine (GEM) and photosensitizer THPP in an optimized ratio. Subsequently, the mixture was added dropwise into amphiphilic polymer DSPE-PEG water solution to form micelles composed of DSPE-PEG nanoparticles (TPG NPs). The TPG NPs were around 135 nm, and showed great ability of DTT stimulated release of PTX and GEM. Moreover, the TPG NPs can be efficiently uptaken by pancreatic cancer PANC-1 cells and effectively kill them, especially when combined with 650 nm laser irradiation. Finally, the TPG NPs have shown enhanced long-term circulation ability and also exhibited efficient anti-tumor activity in combination with 650 nm laser irradiation in a pancreatic cancer mouse model. In summary, the designed TPG NPs possesses great potential for co-delivery of paclitaxel prodrug, GEM and THPP, which enables combined chemo-photodynamic therapy for cancer treatment. In addition, the stimulated release of PTX prodrug and GEM also allows for better targeting of tumor cells and the increased therapeutic effect against cancer cells. Overall, the TPG NPs can serve as a good candidate for pancreatic cancer treatment.
- 25 October 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2280
Open AccessCo-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
Pancreatic carcinoma is an aggressive subtype of cancer with poor prognosis, known for its refractory nature. To address this challenge, we have established a stable nanoplatform that combines chemotherapy with photodynamic therapy (PDT) to achieve better curative efficacy. First, we designed and synthesized a disulfide-bonded paclitaxel (PTX)-based prodrug, which was further mixed with gemcitabine (GEM) and photosensitizer THPP in an optimized ratio. Subsequently, the mixture was added dropwise into amphiphilic polymer DSPE-PEG water solution to form micelles composed of DSPE-PEG nanoparticles (TPG NPs). The TPG NPs were around 135 nm, and showed great ability of DTT stimulated release of PTX and GEM. Moreover, the TPG NPs can be efficiently uptaken by pancreatic cancer PANC-1 cells and effectively kill them, especially when combined with 650 nm laser irradiation. Finally, the TPG NPs have shown enhanced long-term circulation ability and also exhibited efficient anti-tumor activity in combination with 650 nm laser irradiation in a pancreatic cancer mouse model. In summary, the designed TPG NPs possesses great potential for co-delivery of paclitaxel prodrug, GEM and THPP, which enables combined chemo-photodynamic therapy for cancer treatment. In addition, the stimulated release of PTX prodrug and GEM also allows for better targeting of tumor cells and the increased therapeutic effect against cancer cells. Overall, the TPG NPs can serve as a good candidate for pancreatic cancer treatment.
- 10 June 2022
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 16 (5) , 2248-2257
Alterations in degree centrality and cognitive function in breast cancer patients after chemotherapy
The goal of this study was to determine the presence or absence of persistent functional impairments in specific brain regions in breast cancer patients during the recovery period after chemotherapy. We calculated degree centrality (DC) and explored the correlation between brain changes and cognitive scores in 29 female patients with breast cancer who had completed chemotherapy within 1–6 years (C + group) and in 28 age-matched patients with breast cancer who did not receive chemotherapy (C- group). All patients underwent rs-fMRI and cognitive testing. Differences in brain functional activity were explored using DC parameters. Correlations between brain features and cognitive scores were analyzed via correlation analysis. Compared with the C- group, the C + group obtained significantly lower motor and cognitive subscores on the Fatigue Scale for Motor and Cognitive Functions and four subscale scores of the Functional Assessment of Cancer Therapy-Cognitive Function (P < 0.05). Furthermore, the C + group exhibited a significantly higher DC z-score (zDC) in the right superior temporal gyrus and left postcentral gyrus (P < 0.01, FWE-corrected), and a lower zDC in the left caudate nucleus (P < 0.01, FWE-corrected). We found a positive correlation between digit symbol test (DST) scores and zDC values in the right superior temporal gyrus (r = 0.709, P < 0.001), and a negative correlation between DST scores and zDC values in the right angular gyrus (r = -0.784, P < 0.001) and left superior parietal gyrus (r = -0.739, P < 0.001). Chemotherapy can cause abnormal brain activity and cognitive decline in patients with breast cancer, and these effects are likely to persist. DC can be used as an imaging marker for chemotherapy-related cognitive impairment after chemotherapy in breast cancer patients.
- 10 June 2022
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 16 (5) , 2248-2257
Alterations in degree centrality and cognitive function in breast cancer patients after chemotherapy
The goal of this study was to determine the presence or absence of persistent functional impairments in specific brain regions in breast cancer patients during the recovery period after chemotherapy. We calculated degree centrality (DC) and explored the correlation between brain changes and cognitive scores in 29 female patients with breast cancer who had completed chemotherapy within 1–6 years (C + group) and in 28 age-matched patients with breast cancer who did not receive chemotherapy (C- group). All patients underwent rs-fMRI and cognitive testing. Differences in brain functional activity were explored using DC parameters. Correlations between brain features and cognitive scores were analyzed via correlation analysis. Compared with the C- group, the C + group obtained significantly lower motor and cognitive subscores on the Fatigue Scale for Motor and Cognitive Functions and four subscale scores of the Functional Assessment of Cancer Therapy-Cognitive Function (P < 0.05). Furthermore, the C + group exhibited a significantly higher DC z-score (zDC) in the right superior temporal gyrus and left postcentral gyrus (P < 0.01, FWE-corrected), and a lower zDC in the left caudate nucleus (P < 0.01, FWE-corrected). We found a positive correlation between digit symbol test (DST) scores and zDC values in the right superior temporal gyrus (r = 0.709, P < 0.001), and a negative correlation between DST scores and zDC values in the right angular gyrus (r = -0.784, P < 0.001) and left superior parietal gyrus (r = -0.739, P < 0.001). Chemotherapy can cause abnormal brain activity and cognitive decline in patients with breast cancer, and these effects are likely to persist. DC can be used as an imaging marker for chemotherapy-related cognitive impairment after chemotherapy in breast cancer patients.
- Open Access
- 11 January 2022
- Published by Wiley in Journal of Nanomaterials
- Vol. 2022 (1)
The Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy
Prostate cancer is one of the major malignancies that threaten men’s health all over the world. Due to the lack of specific symptoms and signs in the early stage, as well as the limitations of existing detection methods, it is difficult to achieve early diagnosis for prostate cancer. As short single‐stranded oligonucleotides (DNA or RNA) with specific 3D structure which can be produced using an in vitro selection process termed systematic evolution of ligands by exponential enrichment (SELEX), aptamers can specifically bind to the corresponding targets. They have become a class of novel targeting ligand for accurate diagnosis and effective treatment of cancer. Owing to distinctive physicochemical features, and some other special properties such as easy modifiability, good biocompatibility, being easily coupled with other ligands, nanomaterials are extensively used in biological medical field research. Enlighteningly, the combination of aptamers with nanomaterials, including metal nanoparticles, nanosilica, quantum dots, and carbon nanomaterials, can enhance the ability of nanomaterials to recognize tumor cells, which is beneficial to overcome the shortcomings such as low sensitivity in early detection and lack of specificity of traditional antineoplastic drugs, thus, clinically helpful to improve the early metaphase diagnosis rate, providing a technical guarantee for the “personalized treatment” strategy for prostate cancer. Herein, we mainly review the basic and applied research of aptamer functionalized nanocomposite in prostate cancer diagnosis and treatment, including biosensing, bioimaging, and cancer therapy, hoping to provide new ideas for prostate cancer diagnosis and treatment.
- 11 January 2022
- Published by Wiley in Journal of Nanomaterials
- Vol. 2022 (1)
Open AccessThe Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy
Prostate cancer is one of the major malignancies that threaten men’s health all over the world. Due to the lack of specific symptoms and signs in the early stage, as well as the limitations of existing detection methods, it is difficult to achieve early diagnosis for prostate cancer. As short single‐stranded oligonucleotides (DNA or RNA) with specific 3D structure which can be produced using an in vitro selection process termed systematic evolution of ligands by exponential enrichment (SELEX), aptamers can specifically bind to the corresponding targets. They have become a class of novel targeting ligand for accurate diagnosis and effective treatment of cancer. Owing to distinctive physicochemical features, and some other special properties such as easy modifiability, good biocompatibility, being easily coupled with other ligands, nanomaterials are extensively used in biological medical field research. Enlighteningly, the combination of aptamers with nanomaterials, including metal nanoparticles, nanosilica, quantum dots, and carbon nanomaterials, can enhance the ability of nanomaterials to recognize tumor cells, which is beneficial to overcome the shortcomings such as low sensitivity in early detection and lack of specificity of traditional antineoplastic drugs, thus, clinically helpful to improve the early metaphase diagnosis rate, providing a technical guarantee for the “personalized treatment” strategy for prostate cancer. Herein, we mainly review the basic and applied research of aptamer functionalized nanocomposite in prostate cancer diagnosis and treatment, including biosensing, bioimaging, and cancer therapy, hoping to provide new ideas for prostate cancer diagnosis and treatment.
- Open Access
- 31 May 2021
- Published by Wiley in Journal of Nanomaterials
- Vol. 2021, 1-9
The Magnetic Nanomaterial Biofunctions in Cancer Diagnosis and Therapy
Magnetic nanomaterials have recently emerged, playing an increasingly essential role in life science and biomedicine fields, and they exhibited promising potentials in cancer diagnosis and therapy. Also, their use as contrast agents improved various cancer diagnostic imaging sensitivities and accuracy. Magnetic nanomaterials are also exploited as targeted drug carriers to increase the sensitivity and reduce the side effects of chemotherapeutic drugs. Herein, we reviewed the preparation, characterization, and surface modification of various magnetic nanomaterials and their cancer diagnosis and therapy applications.
- 31 May 2021
- Published by Wiley in Journal of Nanomaterials
- Vol. 2021, 1-9
Open AccessThe Magnetic Nanomaterial Biofunctions in Cancer Diagnosis and Therapy
Magnetic nanomaterials have recently emerged, playing an increasingly essential role in life science and biomedicine fields, and they exhibited promising potentials in cancer diagnosis and therapy. Also, their use as contrast agents improved various cancer diagnostic imaging sensitivities and accuracy. Magnetic nanomaterials are also exploited as targeted drug carriers to increase the sensitivity and reduce the side effects of chemotherapeutic drugs. Herein, we reviewed the preparation, characterization, and surface modification of various magnetic nanomaterials and their cancer diagnosis and therapy applications.